Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development
- 1 August 1999
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 3 (4), 388-394
- https://doi.org/10.1016/s1367-5931(99)80059-3
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Changes of benzodiazepine receptors during chronic benzodiazepine administration in humansEuropean Journal of Pharmacology, 1999
- Positron emission tomography (pet) methodology for small animals and its application in radiopharmaceutical preclinical investigationNuclear Medicine and Biology, 1998
- In Vivo Imaging of Neurotransmitter Systems Using Radiolabeled Receptor LigandsNeuropsychopharmacology, 1997
- Guest Editor’s Note: Positron Emission Tomography (PET): A Revolutionary New Approach to Drug Discovery and Development?Drug Information Journal, 1997
- A high resolution animal PET scanner using compact PS-PMT detectorsIEEE Transactions on Nuclear Science, 1997
- The imaging science of positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- The advantage of using positron emission tomography in drug researchTrends in Neurosciences, 1996
- Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium AnalysisJournal of Cerebral Blood Flow & Metabolism, 1989
- Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic DrugsArchives of General Psychiatry, 1988
- Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PETScience, 1986